Literature DB >> 23408552

Computationally-predicted CB1 cannabinoid receptor mutants show distinct patterns of salt-bridges that correlate with their level of constitutive activity reflected in G protein coupling levels, thermal stability, and ligand binding.

Kwang H Ahn1, Caitlin E Scott, Ravinder Abrol, William A Goddard, Debra A Kendall.   

Abstract

The cannabinoid receptor 1 (CB1), a member of the class A G-protein-coupled receptor (GPCR) family, possesses an observable level of constitutive activity. Its activation mechanism, however, has yet to be elucidated. Previously we discovered dramatic changes in CB1 activity due to single mutations; T3.46A, which made the receptor inactive, and T3.46I and L3.43A, which made it essentially fully constitutively active. Our subsequent prediction of the structures of these mutant receptors indicated that these changes in activity are explained in terms of the pattern of salt-bridges in the receptor region involving transmembrane domains 2, 3, 5, and 6. Here we identified key salt-bridges, R2.37 + D6.30 and D2.63 + K3.28, critical for CB1 inactive and active states, respectively, and generated new mutant receptors that we predicted would change CB1 activity by either precluding or promoting these interactions. We find that breaking the R2.37 + D6.30 salt-bridge resulted in substantial increase in G-protein coupling activity and reduced thermal stability relative to the wild-type reflecting the changes in constitutive activity from inactive to active. In contrast, breaking the D2.63 + K3.28 salt-bridge produced the opposite profile suggesting this interaction is critical for the receptor activation. Thus, we demonstrate an excellent correlation with the predicted pattern of key salt-bridges and experimental levels of activity and conformational flexibility. These results are also consistent with the extended ternary complex model with respect to shifts in agonist and inverse agonist affinity and provide a powerful framework for understanding the molecular basis for the multiple stages of CB1 activation and that of other GPCRs in general.
Copyright © 2013 Wiley Periodicals, Inc., a Wiley company.

Entities:  

Keywords:  G-protein coupling; GPCR; constitutive activity; ligand binding; protein structure prediction; thermal stability

Mesh:

Substances:

Year:  2013        PMID: 23408552      PMCID: PMC4872635          DOI: 10.1002/prot.24264

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  82 in total

1.  Activation of CCR5 by chemokines involves an aromatic cluster between transmembrane helices 2 and 3.

Authors:  Cédric Govaerts; Antoine Bondue; Jean-Yves Springael; Mireia Olivella; Xavier Deupi; Emmanuel Le Poul; Shoshana J Wodak; Marc Parmentier; Leonardo Pardo; Cédric Blanpain
Journal:  J Biol Chem       Date:  2002-10-30       Impact factor: 5.157

Review 2.  The [35S]GTPgammaS binding assay: approaches and applications in pharmacology.

Authors:  C Harrison; J R Traynor
Journal:  Life Sci       Date:  2003-12-12       Impact factor: 5.037

3.  The retinal conformation and its environment in rhodopsin in light of a new 2.2 A crystal structure.

Authors:  Tetsuji Okada; Minoru Sugihara; Ana-Nicoleta Bondar; Marcus Elstner; Peter Entel; Volker Buss
Journal:  J Mol Biol       Date:  2004-09-10       Impact factor: 5.469

4.  Porter: a new, accurate server for protein secondary structure prediction.

Authors:  Gianluca Pollastri; Aoife McLysaght
Journal:  Bioinformatics       Date:  2004-12-07       Impact factor: 6.937

5.  Crystal structure of the ligand-free G-protein-coupled receptor opsin.

Authors:  Jung Hee Park; Patrick Scheerer; Klaus Peter Hofmann; Hui-Woog Choe; Oliver Peter Ernst
Journal:  Nature       Date:  2008-06-18       Impact factor: 49.962

6.  Functional role of a conserved motif in TM6 of the rat mu opioid receptor: constitutively active and inactive receptors result from substitutions of Thr6.34(279) with Lys and Asp.

Authors:  P Huang; J Li; C Chen; I Visiers; H Weinstein; L Y Liu-Chen
Journal:  Biochemistry       Date:  2001-11-13       Impact factor: 3.162

7.  Bihelix: Towards de novo structure prediction of an ensemble of G-protein coupled receptor conformations.

Authors:  Ravinder Abrol; Jenelle K Bray; William A Goddard
Journal:  Proteins       Date:  2011-12-15

8.  Active site-directed inactivation of constitutively active mutants of rhodopsin.

Authors:  C P Govardhan; D D Oprian
Journal:  J Biol Chem       Date:  1994-03-04       Impact factor: 5.157

9.  The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist.

Authors:  Veli-Pekka Jaakola; Mark T Griffith; Michael A Hanson; Vadim Cherezov; Ellen Y T Chien; J Robert Lane; Adriaan P Ijzerman; Raymond C Stevens
Journal:  Science       Date:  2008-10-02       Impact factor: 47.728

10.  Crystal structure of the β2 adrenergic receptor-Gs protein complex.

Authors:  Søren G F Rasmussen; Brian T DeVree; Yaozhong Zou; Andrew C Kruse; Ka Young Chung; Tong Sun Kobilka; Foon Sun Thian; Pil Seok Chae; Els Pardon; Diane Calinski; Jesper M Mathiesen; Syed T A Shah; Joseph A Lyons; Martin Caffrey; Samuel H Gellman; Jan Steyaert; Georgios Skiniotis; William I Weis; Roger K Sunahara; Brian K Kobilka
Journal:  Nature       Date:  2011-07-19       Impact factor: 49.962

View more
  16 in total

1.  Ligand- and mutation-induced conformational selection in the CCR5 chemokine G protein-coupled receptor.

Authors:  Ravinder Abrol; Bartosz Trzaskowski; William A Goddard; Alexandre Nesterov; Ivan Olave; Christopher Irons
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-25       Impact factor: 11.205

2.  Probing thermostability of detergent-solubilized CB2 receptor by parallel G protein-activation and ligand-binding assays.

Authors:  Ryan L Beckner; Lioudmila Zoubak; Kirk G Hines; Klaus Gawrisch; Alexei A Yeliseev
Journal:  J Biol Chem       Date:  2019-11-27       Impact factor: 5.157

3.  Allosteric modulators restore orthosteric agonist binding to mutated CB1 receptors.

Authors:  Rachel Dopart; Debra A Kendall
Journal:  J Pharm Pharmacol       Date:  2019-11-13       Impact factor: 3.765

Review 4.  Leveraging allostery to improve G protein-coupled receptor (GPCR)-directed therapeutics: cannabinoid receptor 1 as discovery target.

Authors:  David R Janero; Ganesh A Thakur
Journal:  Expert Opin Drug Discov       Date:  2016-10-21       Impact factor: 6.098

5.  Structures and Agonist Binding Sites of Bitter Taste Receptor TAS2R5 Complexed with Gi Protein and Validated against Experiment.

Authors:  Moon Young Yang; Soo-Kyung Kim; Donghwa Kim; Stephen B Liggett; William A Goddard
Journal:  J Phys Chem Lett       Date:  2021-09-20       Impact factor: 6.888

6.  Computational analysis of the CB1 carboxyl-terminus in the receptor-G protein complex.

Authors:  Joong-Youn Shim; Leepakshi Khurana; Debra A Kendall
Journal:  Proteins       Date:  2016-02-15

7.  SuperBiHelix method for predicting the pleiotropic ensemble of G-protein-coupled receptor conformations.

Authors:  Jenelle K Bray; Ravinder Abrol; William A Goddard; Bartosz Trzaskowski; Caitlin E Scott
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-16       Impact factor: 11.205

8.  Rational design of cannabinoid type-1 receptor allosteric modulators: Org27569 and PSNCBAM-1 hybrids.

Authors:  Thuy Nguyen; Thomas F Gamage; Ann M Decker; David B Finlay; Tiffany L Langston; Daniel Barrus; Michelle Glass; Danni L Harris; Yanan Zhang
Journal:  Bioorg Med Chem       Date:  2021-05-12       Impact factor: 3.461

9.  Anandamide protects HT22 cells exposed to hydrogen peroxide by inhibiting CB1 receptor-mediated type 2 NADPH oxidase.

Authors:  Ji Jia; Lei Ma; Mingchun Wu; Lei Zhang; Xiajing Zhang; Qian Zhai; Tao Jiang; Qiang Wang; Lize Xiong
Journal:  Oxid Med Cell Longev       Date:  2014-07-17       Impact factor: 6.543

10.  Structure-Based Sequence Alignment of the Transmembrane Domains of All Human GPCRs: Phylogenetic, Structural and Functional Implications.

Authors:  Vaclav Cvicek; William A Goddard; Ravinder Abrol
Journal:  PLoS Comput Biol       Date:  2016-03-30       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.